Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Preventive Value of Aflibercept Questioned in NPDR Without CI-DME
Kisspeptin May Be Effective in Treating Men With Low Sexual Desire
Diabetes Treatment Adlyxin Will No Longer Be Available in the US
Subpotent Oral Solution Prompts Recall of Hypothyroidism Treatment
January 2023: Notable Drug Approvals
Persistent Gaps Exist in Continuity of Medication Use for Adults With Diabetes
FDA Clears Automated Insulin Dosing App for Patients With Type 1 Diabetes
Brenzavvy Approved for Adults With Type 2 Diabetes
Rybelsus Now First-Line Option for Type 2 Diabetes Following Label Update
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
Layered Approach Recommended for Patients With Diabetes, CKD
Best Diets According to the Experts: 2023 Rankings Revealed
Guidelines Updated for Reducing Hypoglycemia Risk in Diabetes
Glycemic Control Stagnant in US From 1988 to 2020
First-Line Regimens With Endocrine Therapy Show Benefits in Breast Cancer
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Direct-to-Consumer Testosterone Not Offered in Accordance With Guidelines
Resistant Hypertension Effectively Treated With Novel Drug
